Study Design and Baseline Characteristics of the INFORMS Study: Fingolimod in Patients with Primary Progressive Multiple Sclerosis

被引：0

作者：

Miller, David ^{[1
]}

Cree, Bruce ^{[2
]}

Dalton, Catherine ^{[1
]}

Freedman, Mark ^{[3
]}

Hartung, Hans ^{[4
]}

Kappos, Ludwig ^{[5
]}

Lubetzki, Catherine ^{[6
]}

Lublin, Fred ^{[7
]}

MacManus, David ^{[1
]}

Montalban, Xavier ^{[8
]}

Weiner, Howard ^{[9
]}

Wolinsky, Jerry ^{[10
]}

De Vera, Ana ^{[11
]}

Kornyeyeva, Elena ^{[12
]}

Li, Bingbing ^{[12
]}

Pirozzi, Claudia ^{[12
]}

von Rosenstiel, Philipp ^{[11
]}

Polman, Chris ^{[13
]}

机构：

[1] UCL Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Ottawa Hosp, Ottawa, ON, Canada

[4] Univ Dusseldorf, Dusseldorf, Germany

[5] Univ Basel Hosp, CH-4031 Basel, Switzerland

[6] Hosp Salpetriere, Paris, France

[7] Mt Sinai Med Ctr, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA

[8] Hosp Univ Vall dHebron, Barcelona, Spain

[9] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

[10] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

[11] Novartis Pharma AG, Basel, Switzerland

[12] Novartis Pharmaceut, E Hanover, NJ USA

[13] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P07116

引用

页数：2